8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer)
Published . Updated .
Filed: 2026-10-06 AccNo: 0001104659-26-113895 Size: 206 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events
Directly affected
- REGN Regeneron Pharmaceuticals
Named in this report.
Indirectly affected
- XPH STATE STREET SPDR S&P PHARMACEUTICALS ETF
GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-06 AccNo: 0001104659-26-113895 Size: 206 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events
Source: sec-edgar
Regeneron Pharmaceuticals (REGN) since this story, compared with the market
Since the first closing price after “8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer),” Regeneron Pharmaceuticals (REGN) is +5.28%. The S&P 500 fund (SPY) is -1.36% over the same days, a +6.63% difference versus the market.
Disclosure records for Regeneron Pharmaceuticals (REGN) within two months of 6 Oct 2026
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer)”
Companies mentioned with this story
- REGN Regeneron Pharmaceuticals
In “8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer),” Regeneron Pharmaceuticals (REGN) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> REGN
- XPH State Street Spdr S&P Pharmaceuticals Etf
In “8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer),” State Street Spdr S&P Pharmaceuticals Etf (XPH) is linked, with no stored direction, medium confidence. Reason on file: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer)” reaches Regeneron Pharmaceuticals (REGN)
The 6 Oct 2026 story “8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer)” names Regeneron Pharmaceuticals (REGN) because of this story.
For Regeneron Pharmaceuticals (REGN), the reason on file says SEC 8-K filing -> direct issuer disclosure -> REGN
State Street Spdr S&P Pharmaceuticals Etf (XPH) is here too. Its reason reads: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the Regeneron Pharmaceuticals (REGN) price range
REGN traded between 722.24 and 808.38 across 13 sessions. The latest close on file is 781.40. XPH traded between 61.54 and 68.95 across 20 sessions. The latest close on file is 62.24.
A simple score for Regeneron Pharmaceuticals (REGN)
21 out of 100
“8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer)” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.